Jeffrey Jacobson is a Respiratory physician. ClinicalTrials.gov lists 12 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
909 South Wolcott Avenue
3141 Comrb
Chicago, IL 606123725
Telephone
312-996-8039Registry record last updated 4 Mar 2010.
Clinical trials
- HIV-1-Gag Conserved-Element DNA Vaccine (p24CE) Vaccine Study
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Study of the Safety, Tolerability and Pharmacokinetics of TMB-607 in HIV-Negative Volunteers
Sponsor: TaiMed Biologics Inc.
- DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection
Sponsor: National Cancer Institute (NCI)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
84.6%Corticosteroid43.6%Trelegy Ellipta61%Fluticasone Propionate39%Part D<11 patientsbeta2-Adrenergic Agonist29.1%Albuterol Sulfate Hfa100%Part D≥12 patients+ 1 more class in this area
Metabolism & gastrointestinal
15.4%Corticosteroid15.4%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 2005–2024 per NIH RePORTER. The latest:
- Fostering Academic Physician-Investigators Treating High Risk Populations
University of Illinois at Chicago
FY2024$333,296R38HL155729 - Sphingolipids as Novel Therapeutic Targets in Radiation Lung Injury
University of Illinois at Chicago
FY2023$399,750R01HL147942 - Fostering Academic Physician-Investigators Treating High Risk Populations
University of Illinois at Chicago
FY2023$335,547R38HL155729
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”